Foundation for Promotion of Cardiology / стр. 3 из 30

Main news

Dear colleagues!

On August 28, 2026, the full texts of the new clinical guidelines were published on the official website of the European Society of Cardiology (ESC), dedicated to the issues of cardiovascular diseases and chronic kidney disease.

The provisions of these clinical recommendations were presented to the participants of a number of specially organized scientific sessions, and also served as a reason for active discussions.

Press release

Most important clinical trials presented at the HOT LINE sessions of the European Society of Cardiology Congress 2026 The next Congress of the European Society of Cardiology was held in Munich (Germany) from August 28 to 31, 2026. The motto of this year's event is "Research. Innovation. Inspiration." The Congress participants reviewed 4 new texts of clinical recommendations in various fields of cardiology and other fields of medicine.

ACC and AHA updated their recommendations on statins in 2026 Cardiologists have revised the 2018 statin recommendations. After just under 10 years, during which the target indicators were based solely on percentage reduction, clear numerical target levels for low‑density lipoproteins have been re‑established.

Editorial Activity

cardiology book

Updated recommendations for adults with congenital heart defects On December 18, updated guidelines for management of adults with congenital heart disease, developed by the American College of Cardiology (ACC) and the American Heart Association (AHA) in conjunction with several other societies, were published in Circulation and the Journal of the American College of Cardiology.

Can Interventional EP Go Outpatient? Is interventional electrophysiology poised for a paradigm shift? The American College of Cardiology and Heart Rhythm Society may think so. In a joint scientific statement, they offer guidance on performing certain procedures, such as cardiac ablation, in facilities that provide same-day surgical care without the need for hospital admission.

New Pediatric CPR Guidelines: Key Updates for Clinicians More than 7,000 community-acquired cardiac arrests occur in the United States each year. New methods are aimed at restoring breathing, clearing clogged airways and improving survival.

Upcoming Joint Guidelines to Address Obesity Management Upcoming evidence-based clinical guidelines from three obesity organizations will address US-based pharmacologic management of overweight/obesity and its complications in adults.

Resistant hypertension: a new look Modern management of patients with arterial hypertension requires a consistent approach to treatment and prevention, with particular attention paid to the problem of low adherence to treatment. Lifestyle optimization and elimination of secondary hypertension causes are identified as key strategies.

Results of the 36th International Congress of Cardiology "Great Wall" and the Asian Congress of Cardiology 2025 The 36th International Congress of Cardiology “Great Wall” and the Asian Congress of Cardiology 2025 took place at the National Exhibition Center in Beijing from October 16 to 19, 2025.

New guidelines may help prevent sudden death in myocarditis The European Society of Cardiology (ESC) recently released its 2025 guidelines for the management of myocarditis, which also includes extensive discussion of pericarditis and the wide range of overlap between these types of cardiac inflammation. The guidelines were presented at the ESC Congress 2025 in Madrid and simultaneously published in the European Heart Journal.

Nobel Prize in Physiology or Medicine 2025 The Nobel Prize in Physiology or Medicine 2025 was awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi "for their discoveries concerning peripheral immune tolerance.

Scientific news

Blood Pressure Variability Linked to Mortality in Patients With ANCA-Associated Vasculitis Among patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis undergoing maintenance therapy, greater visit-to-visit systolic blood pressure variability (SBPV) was independently associated with an increased risk for all-cause mortality.

Morphine Underused for End-of-Life Dyspnea in the Emergency Department Compared with Inpatient Care Among 250 patients presenting to the emergency department (ED) with dyspnea at the end of life, 15.2% received morphine in the ED, whereas 68% received it during subsequent inpatient care. Patients with lung cancer or a do-not-resuscitate order were more likely to receive morphine in the ED, but its use was not associated with reduced survival.

Present state and future of screening for atrial fibrillation: a state-of-the-art review Atrial fibrillation is the most common arrhythmia and is a leading cause of stroke and heart failure yet often remains undiagnosed. Screening has been proposed to identify asymptomatic AF and initiate preventive treatment, but evidence for reduction in hard clinical endpoints such as stroke and heart failure remains inconclusive.

Levosimendan versus dobutamine in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials Acute decompensated heart failure with reduced ejection fraction often requires inotropic support. While dobutamine is commonly used, its safety and efficacy remain debated. Levosimendan has emerged as a potential alternative, with distinct pharmacological properties.

Cardiovascular Benefits of Semaglutide in SELECT Trial Not Fully Explained by Weight Loss and Other Improvements In adults with obesity and established cardiovascular disease (CVD), semaglutide was associated with improvements in several risk factors. However, those changes only accounted for part of the reduced risk for major adverse cardiovascular events (MACE) noted in the SELECT trial.

Partners

Video resource

Channel "Cardioprogress"

CARDIOPROGRESS
Foundation for the advancement of cardiology